Literature DB >> 2385251

Clinical and electromyographic studies of postpoliomyelitis muscular atrophy.

J Ravits1, M Hallett, M Baker, J Nilsson, M Dalakas.   

Abstract

Eleven patients with progressive weakness following polio (postpoliomyelitis muscular atrophy syndrome) were compared electromyographically with nine patients who had stable strength following polio. Abnormalities included (1) abnormal motor unit characteristics in many muscles indicating widespread loss of motor neurons and reinnervation in muscles, including many not clinically affected by the polio; (2) prevalent spontaneous denervation potentials; and (3) abnormal single-fiber electromyographic jitter. These electromyographic abnormalities were similar in progressive and stable postpoliomyelitis patients even when muscles were separated by strength, stability, age and duration of the postpoliomyelitis state. Postpoliomyelitis muscular atrophy appears to be the clinically apparent end of the spectrum of abnormalities existing in all postpoliomyelitis patients.

Entities:  

Mesh:

Year:  1990        PMID: 2385251     DOI: 10.1002/mus.880130802

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  4 in total

Review 1.  Poliomyelitis.

Authors:  D Kidd; A J Williams; R S Howard
Journal:  Postgrad Med J       Date:  1996-11       Impact factor: 2.401

2.  Macro EMG follow-up study in post-poliomyelitis patients.

Authors:  B Ivanyi; B W Ongerboer de Visser; P J Nelemans; M de Visser
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

3.  Pyridostigmine in postpolio syndrome: no decline in fatigue and limited functional improvement.

Authors:  H L D Horemans; F Nollet; A Beelen; G Drost; D F Stegeman; M J Zwarts; J B J Bussmann; M de Visser; G J Lankhorst
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

4.  The effects of poliomyelitis on motor unit behavior during repetitive muscle actions: a case report.

Authors:  Michael A Trevino; Trent J Herda; Michael A Cooper
Journal:  BMC Res Notes       Date:  2014-09-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.